HALOZYME THERAPEUTICS INC

CUSIP: 40637HAF6 Class: NOTE 1.000% 8/1

Calamos Advisors LLC's Holding History (CIK: 0001316507)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 11,726,000 Value ($000) $15,585 Avg Close Range
Q3 2025
Shares 40,012,000 Value ($000) $56,379 Avg Close Range
Q2 2025
Shares 39,950,000 Value ($000) $45,631 Avg Close Range
Q1 2025
Shares 39,984,000 Value ($000) $51,244 Avg Close Range
Q4 2024
Shares 39,984,000 Value ($000) $43,228 Avg Close Range
Q3 2024
Shares 40,239,000 Value ($000) $47,940 Avg Close Range
Q2 2024
Shares 63,430,000 Value ($000) $70,576 Avg Close Range
Q1 2024
Shares 63,485,000 Value ($000) $61,933 Avg Close Range
Q4 2023
Shares 63,701,000 Value ($000) $59,324 Avg Close Range
Q3 2023
Shares 63,892,000 Value ($000) $59,889 Avg Close Range